Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Biote (BTMD) Non Operating Income (2021 - 2025)

Biote has reported Non Operating Income over the past 5 years, most recently at -$3000.0 for Q3 2025.

  • Quarterly results put Non Operating Income at -$3000.0 for Q3 2025, down 100.08% from a year ago — trailing twelve months through Sep 2025 was -$27.5 million (down 172.36% YoY), and the annual figure for FY2024 was -$30.6 million, down 84886.11%.
  • Non Operating Income for Q3 2025 was -$3000.0 at Biote, up from -$4.7 million in the prior quarter.
  • Over the last five years, Non Operating Income for BTMD hit a ceiling of $63.9 million in Q2 2022 and a floor of -$56.5 million in Q4 2022.
  • Median Non Operating Income over the past 5 years was -$358500.0 (2021), compared with a mean of -$2.9 million.
  • Biggest five-year swings in Non Operating Income: surged 15284.8% in 2022 and later plummeted 234400.0% in 2025.
  • Biote's Non Operating Income stood at -$368000.0 in 2021, then plummeted by 15263.59% to -$56.5 million in 2022, then skyrocketed by 99.96% to -$22000.0 in 2023, then crashed by 138950.0% to -$30.6 million in 2024, then soared by 99.99% to -$3000.0 in 2025.
  • The last three reported values for Non Operating Income were -$3000.0 (Q3 2025), -$4.7 million (Q2 2025), and $7.8 million (Q1 2025) per Business Quant data.